These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 22751750)
21. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma. Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299 [TBL] [Abstract][Full Text] [Related]
22. Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis. Chai YJ; Kim YA; Jee HG; Yi JW; Jang BG; Lee KE; Park YJ; Youn YK Surgery; 2014 Dec; 156(6):1559-67; discussion 1567-8. PubMed ID: 25456955 [TBL] [Abstract][Full Text] [Related]
23. Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus. Yan Y; Hu F; Wu W; Ma R; Huang H Medicine (Baltimore); 2017 Mar; 96(12):e6393. PubMed ID: 28328831 [TBL] [Abstract][Full Text] [Related]
24. Small interfering RNA survivin and GRIM-19 co-expression salmonella plasmid inhibited the growth of laryngeal cancer cells in vitro and in vivo. Wen LJ; Gao LF; Jin CS; Zhang HJ; Ji K; Yang JP; Zhao XJ; Wen MJ; Guan GF Int J Clin Exp Pathol; 2013; 6(10):2071-81. PubMed ID: 24133585 [TBL] [Abstract][Full Text] [Related]
25. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. Monzó M; Rosell R; Felip E; Astudillo J; Sánchez JJ; Maestre J; Martín C; Font A; Barnadas A; Abad A J Clin Oncol; 1999 Jul; 17(7):2100-4. PubMed ID: 10561264 [TBL] [Abstract][Full Text] [Related]
26. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene. Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791 [TBL] [Abstract][Full Text] [Related]
27. Significance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis. Hammad MO; Elabbasy LM; Abd Elghaffar MA; Zaki MMA; Bazeed FB; Zahran MA Asia Pac J Clin Oncol; 2019 Oct; 15(5):e154-e161. PubMed ID: 30884127 [TBL] [Abstract][Full Text] [Related]
28. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression. Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443 [TBL] [Abstract][Full Text] [Related]
29. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628 [TBL] [Abstract][Full Text] [Related]
30. Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma. Lin S; Meng W; Zhang W; Liu J; Wang P; Xue S; Chen G J Int Med Res; 2013 Jun; 41(3):568-72. PubMed ID: 23685895 [TBL] [Abstract][Full Text] [Related]
31. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337 [TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma. Haghpanah V; Shooshtarizadeh P; Heshmat R; Larijani B; Tavangar SM Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):422-5. PubMed ID: 17122639 [TBL] [Abstract][Full Text] [Related]
33. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells. Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281 [TBL] [Abstract][Full Text] [Related]
34. [Expression of motilin and its precursor mRNA in normal parenchyma, benign and malignant tumors of human thyroid]. Xu L; Zhong F; Guo FF; Zhao WJ; Sun XR; Wei XF Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):243-9. PubMed ID: 18844033 [TBL] [Abstract][Full Text] [Related]
35. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis. Shi Y; Zou M; Farid NR Clin Endocrinol (Oxf); 1993 Sep; 39(3):269-74. PubMed ID: 8222289 [TBL] [Abstract][Full Text] [Related]
36. Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma. Werner TA; Dizdar L; Nolten I; Riemer JC; Mersch S; Schütte SC; Driemel C; Verde PE; Raba K; Topp SA; Schott M; Knoefel WT; Krieg A Sci Rep; 2017 Sep; 7(1):11383. PubMed ID: 28900184 [TBL] [Abstract][Full Text] [Related]
37. Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma. Salajegheh A; Vosgha H; Rahman MA; Amin M; Smith RA; Lam AK Hum Pathol; 2016 May; 51():75-85. PubMed ID: 27067785 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis. Luo W; Matsuo K; Nagayama Y; Urano T; Furukawa K; Takeshita A; Nakayama T; Yokoyama N; Yamashita S; Izumi M Thyroid; 1993; 3(2):105-9. PubMed ID: 8396479 [TBL] [Abstract][Full Text] [Related]
39. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135 [TBL] [Abstract][Full Text] [Related]
40. Clinical significance of mannose-binding lectin expression in thyroid carcinoma tissues. Lu Y; Sun G; Liu G; Shi Y; Han Y; Yu F; Xiang X; Li W; Xiao H; Liu X; Li S Pathol Oncol Res; 2013 Apr; 19(2):259-66. PubMed ID: 23250731 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]